Gyon Technologies Capital Management’s Acceleron Pharma XLRN Stock Holding History

Gyon Technologies Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,358	Closed	-$234K	–	675
2021 Q3	$234K	Sell	1,358 -14,589	-91%	-$1.91M	0.06%	332
2021 Q2	$2M	Buy	15,947 +13,334	+510%	+$1.68M	0.66%	46
2021 Q1	$354K	Buy	+2,613	New	+$338K	0.15%	232

Gyon Technologies Capital Management's XLRN Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,358 shares — an estimated $234K sold.

Gyon Technologies Capital Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $2M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Gyon Technologies Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Gyon Technologies Capital Management sold 1,358 Acceleron Pharma shares in Q4 2021, an estimated $234K.
Gyon Technologies Capital Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Gyon Technologies Capital Management's Acceleron Pharma position peaked at $2M in Q2 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.